Acadian Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-23,658
| Closed | -$4.35M | – | 2149 |
|
|
2021
Q2 | $4.35M | Buy |
23,658
+187
| +0.8% | +$34.4K | 0.02% | 505 |
|
|
2021
Q1 | $3.59M | Sell |
23,471
-17,111
| -42% | -$2.62M | 0.01% | 563 |
|
|
2020
Q4 | $6.34M | Sell |
40,582
-12,822
| -24% | -$2M | 0.02% | 438 |
|
|
2020
Q3 | $6.11M | Sell |
53,404
-5,559
| -9% | -$636K | 0.03% | 404 |
|
|
2020
Q2 | $6.62M | Buy |
+58,963
| New | +$6.62M | 0.03% | 421 |
|
|
2017
Q3 | – | Sell |
-1,316
| Closed | -$160K | – | 1595 |
|
|
2017
Q2 | $160K | Buy |
+1,316
| New | +$160K | ﹤0.01% | 973 |
|
|
2015
Q2 | – | Sell |
-2,902
| Closed | -$503K | – | 1553 |
|
|
2015
Q1 | $503K | Sell |
2,902
-1,022
| -26% | -$177K | ﹤0.01% | 770 |
|
|
2014
Q4 | $726K | Buy |
+3,924
| New | +$726K | ﹤0.01% | 703 |
|